0001775697-20-001378.txt : 20201026 0001775697-20-001378.hdr.sgml : 20201026 20201026073708 ACCESSION NUMBER: 0001775697-20-001378 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20201026 PERIOD START: 20201130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon Strategic Funds, Inc. CENTRAL INDEX KEY: 0000737520 IRS NUMBER: 133272460 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-03940 FILM NUMBER: 201259076 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Strategic Funds, Inc. DATE OF NAME CHANGE: 20060518 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS PREMIER NEW LEADERS FUND INC DATE OF NAME CHANGE: 20021213 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS NEW LEADERS FUND INC DATE OF NAME CHANGE: 19920703 0000737520 S000022407 BNY Mellon U.S. Equity Fund C000064456 Class A DPUAX C000064457 Class C DPUCX C000064458 Class I DPUIX C000130442 Class Y DPUYX NPORT-P 1 primary_doc.xml NPORT-P false 0000737520 XXXXXXXX S000022407 C000064456 C000064457 C000064458 C000130442 BNY Mellon Strategic Funds, Inc. 811-03940 0000737520 549300KOXIZHC0IVRM71 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon U.S. Equity Fund S000022407 549300WPQUILDEF0P640 2020-11-30 2020-08-31 N 751141921.54 541222.79 750600698.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 UST ADOBE INC FU4LY2G4933NH2E1CP29 ADOBE INC 00724F101 43100.00 NS USD 22127109.00 2.9479201174271 Long EC CORP US N 1 N N N AMPHENOL CORP 549300D3L3G0R4U4VT04 AMPHENOL CORP 032095101 182800.00 NS USD 20071440.00 2.6740502684617 Long EC CORP US N 1 N N N AUTOMATIC DATA PROCESSING INC HGBOLILQXWER4SAL2I23 AUTOMATIC DATA PROCESSING INC 053015103 101000.00 NS USD 14048090.00 1.8715796592508 Long EC CORP US N 1 N N N CISCO SYSTEMS INC 8E6NF1YAL0WT6CWXXV93 CISCO SYSTEMS INC 17275R102 360300.00 NS USD 15211866.00 2.0266256113713 Long EC CORP US N 1 N N N CERNER CORP 549300L4UJ40IEVVI304 CERNER CORP 156782104 212400.00 NS USD 15583788.00 2.0761755252762 Long EC CORP US N 1 N N N COLGATE-PALMOLIVE CO 335800YWKI47DGFKWB26 COLGATE-PALMOLIVE CO 194162103 195400.00 NS USD 15487404.00 2.0633346099719 Long EC CORP US N 1 N N N EDWARDS LIFESCIENCES CORP YA13X31F3V31L8TMPR58 EDWARDS LIFESCIENCES CORP 28176E108 204400.00 NS USD 17545696.00 2.3375539123823 Long EC CORP US N 1 N N N EOG RESOURCES INC XWTZDRYZPBUHIQBKDB46 EOG RESOURCES INC 26875P101 136820.00 NS USD 6203418.80 0.8264605682263 Long EC CORP US N 1 N N N FLOWSERVE CORP 6Y0GK87T6V7NJKZJVM41 FLOWSERVE CORP 34354P105 238500.00 NS USD 7078680.00 0.9430686664412 Long EC CORP US N 1 N N EXPEDITORS INTERNATIONAL OF WASHINGTON INC 984500B055A804AB6E40 EXPEDITORS INTERNATIONAL OF WASHINGTON INC 302130109 159700.00 NS USD 14115883.00 1.8806114920366 Long EC CORP US N 1 N N N JOHNSON & JOHNSON 549300G0CFPGEF6X2043 JOHNSON & JOHNSON 478160104 106800.00 NS USD 16384188.00 2.1828101182539 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 109200.00 NS USD 24627876.00 3.2810888720212 Long EC CORP US N 1 N N N ORACLE CORP 529900MIMKY9RU60Z323 ORACLE CORP 68389X105 241900.00 NS USD 13841518.00 1.8440587682706 Long EC CORP US N 1 N N N NIKE INC 787RXPR0UX0O0XUXPZ81 NIKE INC 654106103 174400.00 NS USD 19513616.00 2.5997332579754 Long EC CORP US N 1 N N N ANSYS INC 549300VJV8H15Z5FJ571 ANSYS INC 03662Q105 48000.00 NS USD 16272480.00 2.1679276381036 Long EC CORP US N 1 N N N PAYCHEX INC 529900K900DW6SUBM174 PAYCHEX INC 704326107 172100.00 NS USD 13160487.00 1.7533273046396 Long EC CORP US N 1 N N N MCDONALD'S CORP UE2136O97NLB5BYP9H04 MCDONALD'S CORP 580135101 70800.00 NS USD 15117216.00 2.0140157110398 Long EC CORP US N 1 N N N FMC CORP CKDHZ2X64EEBQCSP7013 FMC CORP 302491303 162500.00 NS USD 17364750.00 2.3134470869688 Long EC CORP US N 1 N N N STRYKER CORP 5493002F0SC4JTBU5137 STRYKER CORP 863667101 59500.00 NS USD 11790520.00 1.5708112208841 Long EC CORP US N 1 N N N WALT DISNEY CO/THE 549300GZKULIZ0WOW665 WALT DISNEY CO/THE 254687106 91500.00 NS USD 12066105.00 1.6075264811362 Long EC CORP US N 1 N N N DOLLAR GENERAL CORP OPX52SQVOZI8IVSWYU66 DOLLAR GENERAL CORP 256677105 93300.00 NS USD 18835404.00 2.5093773602085 Long EC CORP US N 1 N N N ECOLAB INC 82DYEISM090VG8LTLS26 ECOLAB INC 278865100 88100.00 NS USD 17362748.00 2.3131803672598 Long EC CORP US N 1 N N N COGNIZANT TECHNOLOGY SOLUTIONS CORP 5493006IEVQEFQO40L83 COGNIZANT TECHNOLOGY SOLUTIONS CORP 192446102 263000.00 NS USD 17584180.00 2.3426810059307 Long EC CORP US N 1 N N N FASTENAL CO 529900PP0C7H2HHPSJ32 FASTENAL CO 311900104 403800.00 NS USD 19729668.00 2.6285171373882 Long EC CORP US N 1 N N N JACK HENRY & ASSOCIATES INC 529900X1QS8C54W0JB21 JACK HENRY & ASSOCIATES INC 426281101 67600.00 NS USD 11182392.00 1.4897923781076 Long EC CORP US N 1 N N N COGNEX CORP 549300JQTYZCLC43S226 COGNEX CORP 192422103 239700.00 NS USD 16584843.00 2.2095427072768 Long EC CORP US N 1 N N N ILLUMINA INC SQ95QG8SR5Q56LSNF682 ILLUMINA INC 452327109 23600.00 NS USD 8430392.00 1.1231526981042 Long EC CORP US N 1 N N N INTUITIVE SURGICAL INC 54930052SRG011710797 INTUITIVE SURGICAL INC 46120E602 22100.00 NS USD 16151564.00 2.1518184071634 Long EC CORP US N 1 N N N O'REILLY AUTOMOTIVE INC 549300K2RLMQL149Q332 O'REILLY AUTOMOTIVE INC 67103H107 35100.00 NS USD 16343613.00 2.1774044478265 Long EC CORP US N 1 N N N MASTERCARD INC AR5L2ODV9HN37376R084 MASTERCARD INC 57636Q104 58400.00 NS USD 20918296.00 2.7868740376655 Long EC CORP US N 1 N N N WATERS CORP 5T547R1474YC9HOD8Q74 WATERS CORP 941848103 57400.00 NS USD 12413324.00 1.6537852976519 Long EC CORP US N 1 N N N TORO CO/THE YJKE4YIT6BWQHVEW0D14 TORO CO/THE 891092108 174200.00 NS USD 13113776.00 1.7471041556234 Long EC CORP US N 1 N N N TJX COS INC/THE V167QI9I69W364E2DY52 TJX COS INC/THE 872540109 224300.00 NS USD 12289397.00 1.6372749213351 Long EC CORP US N 1 N N N ELI LILLY AND CO FRDRIPF3EKNDJ2CQJL29 ELI LILLY AND CO 532457108 120200.00 NS USD 17836478.00 2.3762938176987 Long EC CORP US N 1 N N N HEXCEL CORP S6Q7LW43WUBUHXY2QP69 HEXCEL CORP 428291108 306700.00 NS USD 12080913.00 1.6094993010423 Long EC CORP US N 1 N N N METTLER-TOLEDO INTERNATIONAL INC 5493000BD5GJNUDIUG10 METTLER-TOLEDO INTERNATIONAL INC 592688105 16900.00 NS USD 16406182.00 2.1857403047081 Long EC CORP US N 1 N N N MANHATTAN ASSOCIATES INC 529900Q1GJP7KD52SW51 MANHATTAN ASSOCIATES INC 562750109 154400.00 NS USD 15015400.00 2.0004511086927 Long EC CORP US N 1 N N N TEXAS INSTRUMENTS INC WDJNR2L6D8RWOEB8T652 TEXAS INSTRUMENTS INC 882508104 106400.00 NS USD 15124760.00 2.0150207727208 Long EC CORP US N 1 N N N IPG PHOTONICS CORP 5493002KZ51CADQ94G15 IPG PHOTONICS CORP 44980X109 99600.00 NS USD 16108308.00 2.1460555561466 Long EC CORP US N 1 N N N RESMED INC 529900T3QE5253CCXF22 RESMED INC 761152107 89300.00 NS USD 16143654.00 2.1507645845366 Long EC CORP US N 1 N N N HENRY SCHEIN INC VGO3WGL8H45T73F4RR92 HENRY SCHEIN INC 806407102 253800.00 NS USD 16862472.00 2.2465302827564 Long EC CORP US N 1 N N N ESTEE LAUDER COS INC/THE 549300VFZ8XJ9NUPU221 ESTEE LAUDER COS INC/THE 518439104 67000.00 NS USD 14855240.00 1.9791135319669 Long EC CORP US N 1 N N N INTERCONTINENTAL EXCHANGE INC 5493000F4ZO33MV32P92 INTERCONTINENTAL EXCHANGE INC 45866F104 136900.00 NS USD 14542887.00 1.9374997950599 Long EC CORP US N 1 N N N BOOKING HOLDINGS INC FXM8FAOHMYDIPD38UZ17 BOOKING HOLDINGS INC 09857L108 6800.00 NS USD 12991060.00 1.730755116753 Long EC CORP US N 1 N N N TE CONNECTIVITY LTD 894500ZRIX9K13RHXR17 TE CONNECTIVITY LTD N/A 169800.00 NS USD 16402680.00 2.1852737450572 Long EC CORP CH N 1 N N N ALPHABET INC 5493006MHB84DD0ZWV18 ALPHABET INC 02079K107 11206.00 NS USD 18312621.08 2.4397287546489 Long EC CORP US N 1 N N N LINDE PLC 8945002PAZHZLBGKGF02 LINDE PLC N/A 82800.00 NS USD 20678472.00 2.7549230948541 Long EC CORP IE N 1 N N N DONALDSON CO INC OZE6KXY9QQPR8EJ8WL20 DONALDSON CO INC 257651109 218800.00 NS USD 11018768.00 1.4679933043427 Long EC CORP US N 1 N N DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT MONEY MARKET N/A Dreyfus Institutional Preferred Government Plus Money Market Fund N/A 7281082.55 OU Other Units USD 7281082.55 0.9700340756577 Long STIV RF US N 1 2099-12-01 Variable 0.201535 N N N N N N 2020-10-22 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10899bnymellonu-august20201.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon U.S. Equity Fund

August 31, 2020 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0%

     

Capital Goods - 8.4%

     

Donaldson

   

218,800

a

11,018,768

 

Fastenal

   

403,800

 

19,729,668

 

Flowserve

   

238,500

a

7,078,680

 

Hexcel

   

306,700

 

12,080,913

 

The Toro Company

   

174,200

 

13,113,776

 
    

63,021,805

 

Consumer Durables & Apparel - 2.6%

     

NIKE, Cl. B

   

174,400

 

19,513,616

 

Consumer Services - 2.0%

     

McDonald's

   

70,800

 

15,117,216

 

Diversified Financials - 1.9%

     

Intercontinental Exchange

   

136,900

 

14,542,887

 

Energy - .8%

     

EOG Resources

   

136,820

 

6,203,419

 

Health Care Equipment & Services - 12.5%

     

Cerner

   

212,400

 

15,583,788

 

Edwards Lifesciences

   

204,400

b

17,545,696

 

Henry Schein

   

253,800

b

16,862,472

 

Intuitive Surgical

   

22,100

b

16,151,564

 

ResMed

   

89,300

 

16,143,654

 

Stryker

   

59,500

 

11,790,520

 
    

94,077,694

 

Household & Personal Products - 4.1%

     

Colgate-Palmolive

   

195,400

 

15,487,404

 

The Estee Lauder Companies, Cl. A

   

67,000

 

14,855,240

 
    

30,342,644

 

Materials - 7.4%

     

Ecolab

   

88,100

 

17,362,748

 

FMC

   

162,500

 

17,364,750

 

Linde

   

82,800

 

20,678,472

 
    

55,405,970

 

Media & Entertainment - 4.1%

     

Alphabet, Cl. C

   

11,206

b

18,312,621

 

The Walt Disney Company

   

91,500

 

12,066,105

 
    

30,378,726

 

Pharmaceuticals Biotechnology & Life Sciences - 9.5%

     

Eli Lilly & Co.

   

120,200

 

17,836,478

 

Illumina

   

23,600

b

8,430,392

 

Johnson & Johnson

   

106,800

 

16,384,188

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0% (continued)

     

Pharmaceuticals Biotechnology & Life Sciences - 9.5% (continued)

     

Mettler-Toledo International

   

16,900

b

16,406,182

 

Waters

   

57,400

b

12,413,324

 
    

71,470,564

 

Retailing - 8.1%

     

Booking Holdings

   

6,800

b

12,991,060

 

Dollar General

   

93,300

 

18,835,404

 

O'Reilly Automotive

   

35,100

b

16,343,613

 

The TJX Companies

   

224,300

 

12,289,397

 
    

60,459,474

 

Semiconductors & Semiconductor Equipment - 2.0%

     

Texas Instruments

   

106,400

 

15,124,760

 

Software & Services - 22.5%

     

Adobe

   

43,100

b

22,127,109

 

Ansys

   

48,000

b

16,272,480

 

Automatic Data Processing

   

101,000

 

14,048,090

 

Cognizant Technology Solutions, Cl. A

   

263,000

 

17,584,180

 

Jack Henry & Associates

   

67,600

 

11,182,392

 

Manhattan Associates

   

154,400

b

15,015,400

 

Mastercard, Cl. A

   

58,400

 

20,918,296

 

Microsoft

   

109,200

 

24,627,876

 

Oracle

   

241,900

 

13,841,518

 

Paychex

   

172,100

 

13,160,487

 
    

168,777,828

 

Technology Hardware & Equipment - 11.2%

     

Amphenol, Cl. A

   

182,800

 

20,071,440

 

Cisco Systems

   

360,300

 

15,211,866

 

Cognex

   

239,700

 

16,584,843

 

IPG Photonics

   

99,600

b

16,108,308

 

TE Connectivity

   

169,800

 

16,402,680

 
    

84,379,137

 

Transportation - 1.9%

     

Expeditors International of Washington

   

159,700

 

14,115,883

 

Total Common Stocks (cost $396,354,635)

   

742,931,623

 
  

1-Day
Yield (%)

     

Investment Companies - .9%

     

Registered Investment Companies - .9%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund
(cost $7,281,083)

 

0.20

 

7,281,083

c

7,281,083

 

Total Investments (cost $403,635,718)

 

99.9%

 

750,212,706

 

Cash and Receivables (Net)

 

.1%

 

387,993

 

Net Assets

 

100.0%

 

750,600,699

 


a Security, or portion thereof, on loan. At August 31, 2020, the value of the fund’s securities on loan was $5,446,460 and the value of the collateral was $5,690,833, consisting of U.S. Government & Agency securities.

b Non-income producing security.

c Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
BNY Mellon U.S. Equity Fund

August 31, 2020 (Unaudited)

The following is a summary of the inputs used as of August 31, 2020 in valuing the fund’s investments:

     
 

Level 1 - Unadjusted Quoted Prices

Level 2 - Other Significant Observable Inputs

Level 3 -Significant Unobservable Inputs

Total

Assets ($)

    

Investments in Securities:

  

Equity Securities—Common Stocks

742,931,623

-

-

742,931,623

Investment Companies

7,281,083

-

-

7,281,083

See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the fund's Board (the "Board"). Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a


result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At August 31, 2020, accumulated net unrealized appreciation on investments was $346,576,988, consisting of $356,159,925 gross unrealized appreciation and $9,582,937 gross unrealized depreciation.

At August 31, 2020, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.